Press Resease

Heart Valve Devices Market - Global Industry Analysis

Heart Valve Devices Market by Procedure (Heart Valve Replacement Devices [Mechanical Valve, Bioprosthetic Valve, TAVR) & Position (Mitral Valve, Aortic Valve, Other)], and Heart Valve Repair Devices [Surgical Valve, Balloon Valvuloplasty Devices, TMVR)] By End User (Hospital, Ambulatory, and Surgical Centers): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 26-Jul-2021 Category: Medical Device Report Format : PDF Pages: 165 Report Code: ZMR-2511 Status : Published

The global Heart Valve Devices market accounted for USD 7.8 Billion in 2020 and is expected to reach USD 21.2 Billion by 2028, growing at a CAGR of around 13.2% between 2021 and 2028.

Description

Market Overview                            

The global Heart Valve Devices market accounted for USD 7.8 Billion in 2020 and is expected to reach USD 21.2 Billion by 2028, growing at a CAGR of around 13.2% between 2021 and 2028.      

Heart valve disease occurs when one or more heart valves fail to open and close properly. This can affect the ability of heart to pump blood. To prevent and cure the disease the heart valve devices are used. Heart valve disease can be congenital or occurred later in life due to age related changes, heart attack, infections, among others.

More than 5 million people in the United States are diagnosed with heart valve disease each year. Almost all of these surgeries are done to repair or replace the valves. These valves are replaced with the prosthetic valve to treat any diseased valve that cannot be repaired.

The key players in the market are focusing on investing on R&D in order to launch new technologies for making heart valve procedure safer and more effective in the market. For instance, in September 2018, LivaNova—a medical technology firm—introduced the international pivotal study for determining the application of autonomic regulation treatment for heart failure. Reportedly, the firm entrenched the Vitaria system in a patient during the autonomic regulation treatment to improve myocardial functioning and minimize the cases of progress of heart failures in patients with reduced ejection fraction.

COVID-19 Impact Analysis:   

Due to government-imposed lockdowns to prevent the spreading of COVID, the global Heart Valve Devices industry has seen a small decline in revenues in the short. As healthcare professionals increasingly direct their resources towards caring for coronavirus-infected patients, other health issues are being relegated to the back seat. The players in the industry have temporarily suspended the production of heart valves device in order to cater corona virus patients.

The significant decrease in the global Heart Valve Devices market size in 2020 is estimated on the basis of the COVID-19 outbreak and its negative impact on the economies and industries across the globe. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.

Growth Factors

Inactive lifestyle of the global population leading to rise in the proportion of obesity among the individuals is expected to propel the growth of heart valve devices market in the years ahead. Apart from this, mammoth demand for minimally invasive procedures as a result of increase in cardiac & pathological disorders along with persistent product innovations are few of the key growth drivers of heart valve devices market.

Complicated regulatory procedures and high costs of procedures &devices, however, are predicted to restrict the growth of the heart valve devices market in the upcoming years. Nevertheless, heart valve ailments can cause heart failure, blood clots, stroke, and death of patients and hence requires effecting handling of the heart valve disease. This is anticipated to boost heart valve devices market demand in the next few years, thereby normalizing the impact of hindrances on the heart valve devices market.

 Report Scope:  

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Segment Analysis Preview  

On the basis of Procedure, Heart Valve Devices market has been divided as Heart Valve Replacement Devices and Heart Valve Repair Devices. Heart Valve repair devices segment held the major share in the market. This is attributed to new and innovative products are being launched in the market. Moreover, factors such as high cost of devices and surgeries, complex regulatory procedures and varied stringency of regulatory procedures may hinder the growth of the market to some extent.

On the basis of End User, the market is segmented into Hospital and Ambulatory Surgical Centers. Hospital dominated the Heart Valve Devices industry in 2020, accounting for almost 56.2% of total Heart Valve Devices sales.

Regional Analysis Preview  

Regionally, North America has been leading the worldwide heart valve devices market and is anticipated to continue on the dominant position in the years to come, states the heart valve devices market study. Massive application of technologically superior products and growing incidences of heart diseases in the region is the main factor behind the dominance of the North America heart valve devices market. The presence of market players such as Boston Scientific Corporation, Abbott Laboratories, and Medtronic Incorporation in the countries such as the U.S. in North America is another significant factor that is supporting the growth of this regional heart valve devices market.

Key Market Players & Competitive Landscape

The major players operating Heart Valve Devices market are Abbott, Medtronic, CryoLife, Inc., Boston Scientific Corporation, Micro Interventional Devices, Inc., Neovasc, Inc., Edward Lifesciences Corporation, Sorin Group, TTK HealthCare, JenaValve Technology, Inc., and Lepu Medical Technology Co., Ltd. among others.    

 The global Heart Valve Devices Market is segmented as follows:

By Procedure

  • Heart Valve Replacement Devices
    • Mechanical Valve
    • Bioprosthetic Valve
    • TAVR & Position (Mitral Valve, Aortic Valve, Other)
  • Heart Valve Repair Devices
    • Surgical Valve
    • Balloon Valvuloplasty Devices,
    • TMVR

By End User  

  • Hospital  
  • Ambulatory Surgical Centers

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Procedure
        • 2.1.1.2. Market Attractiveness Analysis, By End User
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Heart Valve Devices Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Heart Valve Devices Market – Procedure Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Procedure, 2020 & 2028
    • 4.2. Heart Valve Replacement Devices
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
      • 4.2.4. Mechanical Valve
      • 4.2.5. Bioprosthetic Valve
      • 4.2.6. TAVR & Position
    • 4.3. Heart Valve Repair Devices
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
      • 4.3.4. Surgical Valve
      • 4.3.5. Balloon Valvuloplasty Devices
      • 4.3.6. TMVR
  • Chapter No. 5 Heart Valve Devices Market – End User Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By End User, 2020 & 2028
    • 5.2. Hospital
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Ambulatory Surgical Centers
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By Procedure, 2016 – 2028
      • 6.2.3. North America Market Revenue, By End User, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Procedure, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By End User, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Procedure, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By End User, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Procedure, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By End User, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By Procedure, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By End User, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Procedure, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By End User, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Procedure, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By End User, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Procedure, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By End User, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Procedure, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By End User, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Procedure, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By End User, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Procedure, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By End User, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By Procedure, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By End User, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Procedure, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By End User, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Procedure, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By End User, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Procedure, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By End User, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Procedure, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By End User, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Procedure, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By End User, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Procedure, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By End User, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By Procedure, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By End User, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Procedure, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By End User, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Procedure, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By End User, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Procedure, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By End User, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Procedure, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By End User, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Procedure, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By End User, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Procedure, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By End User, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Procedure, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By End User, 2016 – 2028
  • Chapter No. 7: Heart Valve Devices Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Procedure Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Heart Valve Devices Market: Company Market Share, 2019
      • 8.1.2. Global Heart Valve Devices Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 8.1.3. Global Heart Valve Devices Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Heart Valve Devices Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Procedure Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. Abbott
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Procedure Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Medtronic
    • 9.3. CryoLife, Inc
    • 9.4. Boston Scientific Corporation
    • 9.5. Micro Interventional Devices, Inc
    • 9.6. Neovasc, Inc
    • 9.7. Edward Lifesciences Corporation
    • 9.8. Sorin Group
    • 9.9. TTK HealthCare
    • 9.10. JenaValve Technology, Inc
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Procedure
FIG NO. 2. Market Attractiveness Analysis, By End User
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Heart Valve Devices Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Procedure, 2020 & 2028 
FIG NO. 7. Global Heart Valve Devices Market for Heart Valve Replacement Devices, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Heart Valve Devices Market for Heart Valve Replacement Devices, By Country, 2020 & 2028
FIG NO. 9. Global Heart Valve Devices Market for Heart Valve Repair Devices, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Heart Valve Devices Market for Heart Valve Repair Devices, By Country, 2020 & 2028
FIG NO. 11. Market Revenue Share, By End User, 2020 & 2028
FIG NO. 12 Global Heart Valve Devices Market for Hospital, Revenue (USD Billion) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Heart Valve Devices Market for Hospital, By Country, 2020 & 2028 
FIG NO. 14. Global Heart Valve Devices Market for Ambulatory Surgical Centers, Revenue (USD Billion) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of Heart Valve Devices Market for Ambulatory Surgical Centers, By Country, 2020 & 2028
FIG NO. 16. Global Heart Valve Devices Market Revenue Share, By Region, 2020 & 2028
FIG NO. 17. North America Heart Valve Devices Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 18. Porter’s Five Forces Analysis for Global Heart Valve Devices Market
FIG NO. 19. PEST Analysis for Global Heart Valve Devices Market
FIG NO. 20. Pricing Analysis for Global Heart Valve Devices Market
FIG NO. 21. Value Chain Analysis for Global Heart Valve Devices Market
FIG NO. 22. Company Share Analysis, 2019
FIG NO. 23. Radar Determinant Chart, 2019
FIG NO. 24. Company Strategic Developments – Heat Map Analysis
FIG NO. 25. Abbott Business Segment Revenue Share, 2020 (%)
FIG NO. 26. Abbott Geographical Segment Revenue Share, 2020 (%)
FIG NO. 27. Market Channels 
FIG NO. 28. Marketing Channel Development Trend
FIG NO. 29. Growth in World Gross Procedure, 2008-2018
FIG NO. 30. Research Methodology – Detailed View
FIG NO. 31. Research Methodology
 


List of Tables 

TABLE NO. 1. Global Heart Valve Devices Market: Snapshot
TABLE NO. 2. Quarterly Heart Valve Devices Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Heart Valve Devices Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion) 
TABLE NO. 6. Global Heart Valve Devices Market for Heart Valve Replacement Devices, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Heart Valve Devices Market for Heart Valve Repair Devices, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8: Global Heart Valve Devices Market for Hospital, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9: Global Heart Valve Devices Market for Ambulatory Surgical Centers, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Heart Valve Devices Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 11: North America Heart Valve Devices Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 12. North America Heart Valve Devices Market Revenue, By Procedure, 2016 – 2028 (USD Billion)
TABLE NO. 13: North America Heart Valve Devices Market Revenue, By End User, 2016 – 2028 (USD Billion)
TABLE NO. 14. U.S. Heart Valve Devices Market Revenue, By Procedure, 2016 – 2028 (USD Billion)
TABLE NO. 15. U.S. Heart Valve Devices Market Revenue, By End User, 2016 – 2028 (USD Billion)
TABLE NO. 16 Canada Heart Valve Devices Market Revenue, By Procedure, 2016 – 2028 (USD Billion)
TABLE NO. 17. Canada Heart Valve Devices Market Revenue, By End User, 2016 – 2028 (USD Billion)
TABLE NO. 18. Mexico Heart Valve Devices Market Revenue, By Procedure, 2016 – 2028 (USD Billion)
TABLE NO. 19. Mexico Heart Valve Devices Market Revenue, By End User, 2016 – 2028 (USD Billion)
TABLE NO. 20. Drivers for the Heart Valve Devices Market: Impact Analysis
TABLE NO. 21. Restraints for the Heart Valve Devices Market: Impact Analysis
TABLE NO. 22. Major Buyers of Heart Valve Devices  
TABLE NO. 23. Distributors/Traders List of Heart Valve Devices 
TABLE NO. 24. Global Heart Valve Devices Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 25: Global Heart Valve Devices Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)   
 

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Heart Valve Devices market. Zion Research has collected and analyzed key data belong to the global Heart Valve Devices market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Heart Valve Devices across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Heart Valve Devices industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Heart Valve Devices market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

In mammals, four heart valves are there (mitral valve, tricuspid valve, aortic valve, and pulmonary valve) which responsible for keep blood flow in right direction. Sometimes, one or more of the valves don't open or close properly. This results in the blood flow through your heart to your body to be disrupted. It’s called as heart valve disease, and treatment of heart valve disease depends on the heart valve affected and the type and severity of the valve disease. Heart valve disease may require surgery to repair or replace the heart valve. Regurgitation, stenosis, and atresia are basic problems related to the heart valve. Heart valve disease can be present at birth, or it can also occur in adults due to many causes and conditions, such as infections and other heart conditions. Factors which can increase the risk of heart valve disease are older age, history of certain infections that can affect the heart, certain forms of heart disease or heart attack, high blood pressure, high cholesterol, diabetes and other heart disease risk factors, and heart conditions present at birth (congenital heart disease).

Increasing sedentary lifestyle triggering the rate of obesity and growing various cardiac diseases and pathological disorders are some of the major drivers of Heart Valve Devices Market. According to Heart Valve Society of America, more than 5 million Americans are suffering from heart valve disease. Many people left undiagnosed and untreated, as their condition can cause a progressive deterioration in heart function, which can result in heart failure and premature death. Symptoms of heart valve diseases are shortness of breath and/or difficulty catching your breath, discomfort in your chest, weakness, irregular heartbeat, swelling of your ankles, feet or abdomen and rapid weight gain. This symptom may occur or may not in some people; it slowly develops and worsens over time which may cause the death of a person. However, complex regulatory procedures and the high price of devices and procedure may hamper the growth of the heart valve devices market. However, growth in transcatheter heart valves and demand for heart valve devices in the Asia Pacific region may create a significant opportunity for heart valve devices market in the coming years.

Global-Heart-Valve-Devices-Market.png

The Heart Valve Devices Market is classified based on procedure, end-user, and region. On the basis of procedure, the market is divided into heart valve replacement devices and heart valve repair devices. Heart valve replacement devices are further sub-segmented on the basis of techniques as a mechanical valve, Bioprosthetic valve and TAVR (Transcatheter Aortic Valve Replacement). Heart valve replacement devices are further sub-segmented on the basis of the position where they are replaced as mitral valve replacement devices, aortic valve replacement devices, and other position heart valve replacement devices. Heart valve repair devices are further sub-segmented on the basis of techniques as surgical valve repair devices, balloon valvuloplasty devices and TMVR (Transcatheter Mitral Valve Repair). Due to the escalating use of technologically superior products, more than average selling prices, and considerably lower mortality rate achieved by the devices, the transcatheter heart valve devices accounts for maximum share in the market. On the basis of the end-user market is divided into hospitals and ambulatory surgical centers.

By geography, North America dominates the Heart Valve Devices Market owing rising usage of technologically superior products in this region. Other major driving factors in the North America region is increasing rate of obesity and prevalence of cardiac diseases in this region. Additionally, the presence of major market players, such as Boston Scientific Corporation, Abbott, and Medtronic, in the U.S. is anticipated to contribute significantly to the revenue generation of the country. Europe is also a major market for heart valve devices market due to supportive policies of the government, number of product launches, and a large pool of elderly highly susceptible to various heart diseases.

In Asia Pacific region due to the high prevalence of heart valve diseases and developing healthcare, infrastructure creates significant opportunity in the near future. The Middle East and Africa are anticipated to witness significant growth during the forecast period.

Some of the key players in Heart Valve Devices Market include Abbott, Medtronic, CryoLife, Inc., Boston Scientific Corporation, Micro Interventional Devices, Inc., Neovasc, Inc., Edward Lifesciences Corporation, Sorin Group, TTK HealthCare, JenaValve Technology, Inc., and Lepu Medical Technology Co., Ltd. among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global Heart Valve Devices Market was valued at USD 7.8 Billion in 2020.

The global Heart Valve Devices Market is expected to reach USD 21.2 Billion by 2028, growing at a CAGR of 13.2% between 2021 to 2028.  

Some of the key factors driving the global Heart Valve Devices Market growth are Inactive lifestyle of the global population leading to rise in the proportion of obesity among the individuals.  

North America has been leading the worldwide heart valve devices market and is anticipated to continue on the dominant position in the years to come, states the heart valve devices market study. Massive application of technologically superior products and growing incidences of heart diseases in the region is the main factor behind the dominance of the North America heart valve devices market..  

Some of the major players of global Heart Valve Devices market includes Abbott, Medtronic, CryoLife, Inc., Boston Scientific Corporation, Micro Interventional Devices, Inc., Neovasc, Inc., Edward Lifesciences Corporation, Sorin Group, TTK HealthCare, JenaValve Technology, Inc., and Lepu Medical Technology Co., Ltd. among others.

 

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed